Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Anika Therapeutics Inc. (ANIK) had Receiveable Turnover of 1.25 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$27.82M |
|
$-2.33M |
|
$12.23M |
|
$15.58M |
|
$31.05M |
|
$-3.23M |
|
$1.00M |
|
$-2.24M |
|
$-2.24M |
|
$-3.17M |
|
$-3.17M |
|
$-2.33M |
|
$-3.17M |
|
$-3.23M |
|
$-1.83M |
|
14.42M |
|
14.42M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$101.59M |
|
$40.68M |
|
$87.85M |
|
$189.44M |
|
$19.09M |
|
-- |
|
$23.54M |
|
$42.63M |
|
$146.81M |
|
$137.10M |
|
$146.81M |
|
14.42M |
|
| Cash Flow Statement Financials | |
$6.55M |
|
$-0.60M |
|
$-5.27M |
|
$57.16M |
|
$57.99M |
|
$0.83M |
|
$7.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
56.02% |
|
-11.62% |
|
-11.62% |
|
-- |
|
-8.04% |
|
-8.37% |
|
$0.97M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.75 |
|
|
Receiveable Turnover |
1.25 |
71.78 |
|
-2.16% |
|
-2.32% |
|
-1.68% |
|
-2.16% |
|
$10.18 |
|
$0.07 |
|
$0.45 |
|